VeriTeQ Corp. Bundle
What's the Story Behind VeriTeQ Corp's Transformation?
Ever wondered how a company pivots from cutting-edge tech to a broader healthcare model? VeriTeQ Corporation's journey, now known as Consensus Health, offers a fascinating case study. This company, initially focused on innovative RFID technology, has undergone a significant evolution. Discover the key milestones and strategic shifts that shaped VeriTeQ Corp. SWOT Analysis.
Delving into the VeriTeQ history reveals a commitment to leveraging technology for improved patient care, starting with implantable microchips. The VeriTeQ company navigated challenges, including funding limitations, while staying true to its mission. Understanding the VeriTeQ Corp background provides valuable insights into the dynamics of innovation and strategic adaptation within the healthcare sector, making it a compelling story for investors and strategists alike.
What is the VeriTeQ Corp. Founding Story?
The story of VeriTeQ Corp, a company with a focus on radio frequency identification (RFID) technology, began in the early 1990s. Understanding the VeriTeQ history provides insight into its strategic shifts and technological focus. The company's journey includes acquisitions and developments aimed at the medical device market.
VeriTeQ Corporation's origins are linked to its incorporation in Missouri on May 11, 1993. A significant milestone was the establishment of VeriTeQ Acquisition Corporation (VAC) in December 2011. VAC was created to develop RFID technologies, specifically for the Unique Device Identification (UDI) of implantable medical devices. This marked a pivotal shift towards the medical technology sector.
Key figures, such as Scott R. Silverman, played crucial roles in the leadership of both VeriTeQ Corp. and VeriTeQ Acquisition Corp. from 2011 to 2016. The company's early strategy focused on leveraging RFID technology for patient safety and medical device tracking. This involved acquiring and developing technologies aimed at improving the identification and management of implantable medical devices.
Key Milestones in VeriTeQ Corp's Early Days
The VeriTeQ timeline includes key acquisitions and strategic moves that shaped its direction.
- In January 2012, VAC acquired PositiveID Animal Health Corporation, gaining the rights to the FDA-cleared VeriChip technology.
- This acquisition included the Health Link web-based personal health record system.
- The initial focus was on supplying microchips and readers to medical device manufacturers, targeting devices like breast implants.
- The goal was to improve patient safety and device traceability.
The acquisition of PositiveID Animal Health Corporation was a critical step, providing VeriTeQ with the VeriChip technology. This technology, which had received FDA approval for human use in 2004, became a cornerstone of the company's early business model. The company aimed to capitalize on the potential of RFID technology to enhance patient safety and streamline medical device management. For more details on the company's business model, you can explore Revenue Streams & Business Model of VeriTeQ Corp.
Early efforts focused on securing financing to commercialize its technologies. The company's early days were characterized by attempts to secure funding and establish its market position within the medical device sector. The company's strategic moves and technological focus highlight its commitment to leveraging RFID technology for patient safety and medical device tracking.
VeriTeQ Corp. SWOT Analysis
- Complete SWOT Breakdown
- Fully Customizable
- Editable in Excel & Word
- Professional Formatting
- Investor-Ready Format
What Drove the Early Growth of VeriTeQ Corp.?
The early growth of VeriTeQ Corp was marked by strategic moves and a focus on emerging regulations. The company's trajectory involved acquisitions and partnerships aimed at establishing a strong foothold in the healthcare technology sector. This period was crucial for laying the groundwork for its future endeavors. This article explores the VeriTeQ history and its significant developments.
Acquisitions and Strategic Positioning
In January 2012, VeriTeQ Corporation acquired PositiveID Animal Health Corporation, which included the FDA-cleared VeriChip technology. This acquisition was pivotal, positioning VeriTeQ to develop implantable RFID solutions. These solutions were intended for patient identification, sensor applications, and medical device identification within the body. The company aimed to capitalize on the growing need for advanced identification technologies.
Reverse Acquisition and Name Change
A significant corporate restructuring occurred on July 8, 2013, when VeriTeQ Acquisition Corporation (VAC) became a wholly-owned subsidiary of Digital Angel Corporation. This was a reverse acquisition, with VAC acting as the accounting acquirer. Subsequently, on October 18, 2013, Digital Angel Corporation changed its name to VeriTeQ Corporation, solidifying its identity and strategic direction.
Focus on UDI and Partnerships
During this period, VeriTeQ Corp concentrated on providing RFID technologies for the Unique Device Identification (UDI) of implantable medical devices and radiation dose measurement technologies. A key partnership was formed in August 2013 with Establishment Labs, S.A. (Motiva), to manufacture and market breast implants embedded with VeriTeQ's 'Q Inside' microchip. This partnership underscored the company's commitment to innovation in the medical device sector.
Market Potential and Challenges
While the company had FDA cleared and CE marked dosimetry technologies, commercialization was hindered by a lack of available funds. The company's business model aimed to supply microchips and readers to medical device manufacturers. The global RFID in healthcare market was valued at approximately USD 6.52 billion in 2024 and is projected to reach around USD 31.23 billion by 2034, growing at a CAGR of 16.96%. This highlights the significant market potential VeriTeQ aimed to tap into. For more details on the company's early days, see this [VeriTeQ Corp company profile](0).
VeriTeQ Corp. PESTLE Analysis
- Covers All 6 PESTLE Categories
- No Research Needed – Save Hours of Work
- Built by Experts, Trusted by Consultants
- Instant Download, Ready to Use
- 100% Editable, Fully Customizable
What are the key Milestones in VeriTeQ Corp. history?
The VeriTeQ Corp, a company with a rich history, achieved several significant milestones, particularly in the realm of implantable RFID technology for medical devices. These advancements marked key points in the VeriTeQ history and its overall company background.
| Year | Milestone |
|---|---|
| 2004 | FDA approval was granted for implantable microchips for specific medical uses. |
| 2013 | Collaboration with Establishment Labs, S.A. (Motiva) to integrate RFID microchips into breast implants. |
| 2014 | The company stated its inability to commercialize dosimetry technologies due to funding constraints. |
| 2016 | Acquisition by Jamm Technologies, leading to the evolution into Consensus Health. |
VeriTeQ's innovations centered on implantable RFID technology and radiation dose measurement. Their proprietary RFID microchip technology, branded as 'Q Inside Safety Technology,' received FDA clearance and CE mark for use in medical devices.
RFID Microchip Technology
Developed a proprietary RFID microchip for medical devices, enabling identification from outside the body.
'Q Inside Safety Technology'
The technology, branded as 'Q Inside Safety Technology', was designed to be embedded within implantable medical devices.
Collaboration with Establishment Labs
Partnered with Establishment Labs to integrate the microchip into breast implants, enhancing traceability.
Radiation Dose Measurement
Pursued technologies for measuring radiation doses in radiation therapy, aiming to improve patient safety.
Despite technological advancements, VeriTeQ Corporation faced challenges, especially in securing funding. A lack of capital hindered the company's ability to commercialize its dosimetry technologies, as explicitly stated in 2014.
Funding Constraints
The primary challenge was a persistent lack of funding, which hampered commercialization efforts.
Market Acceptance
Limited public acceptance of implantable microchips posed a broader market challenge.
Commercialization Issues
The company's inability to generate sales revenue until a significant capital raise was a major impediment.
Strategic Pivot
The acquisition by Jamm Technologies and subsequent transition to Consensus Health reflected a strategic shift.
VeriTeQ Corp. Business Model Canvas
- Complete 9-Block Business Model Canvas
- Effortlessly Communicate Your Business Strategy
- Investor-Ready BMC Format
- 100% Editable and Customizable
- Clear and Structured Layout
What is the Timeline of Key Events for VeriTeQ Corp.?
The VeriTeQ Corp. company background reveals a journey marked by strategic shifts and acquisitions. Initially incorporated in Missouri, VeriTeQ Corporation later re-incorporated in Delaware and transitioned its focus to RFID technology, particularly for medical device identification. Through various acquisitions and partnerships, the company explored opportunities in implantable RFID technology and expanded into the medical device market. Ultimately, VeriTeQ Corp. was acquired and transformed into Consensus Health, a physician-owned medical group.
| Year | Key Event |
|---|---|
| May 11, 1993 | Initial incorporation of VeriTeQ Corporation in Missouri. |
| April 20, 2007 | Re-incorporation as a Delaware corporation. |
| December 2011 | Founding of VeriTeQ Acquisition Corporation (VAC) with a focus on RFID for Unique Device Identification (UDI) of implantable medical devices. |
| January 2012 | VAC acquires PositiveID Animal Health Corporation, including the FDA-cleared VeriChip implantable RFID technology. |
| July 8, 2013 | VAC becomes a wholly-owned subsidiary of Digital Angel Corporation (which then became the legal acquirer, with VAC as the accounting acquirer in a reverse acquisition). |
| August 7, 2013 | VeriTeQ partners with Establishment Labs, S.A. (Motiva) to integrate 'Q Inside' microchips into breast implants. |
| October 18, 2013 | Digital Angel Corporation officially changes its name to VeriTeQ Corporation. |
| April 4, 2016 | VeriTeQ Corporation is acquired by Jamm Technologies. |
| May 2021 | Michael Lovett joins Consensus Health as Chief Operating Officer. |
| January 1, 2024 | Michael Lovett assumes the role of Chief Executive Officer of Consensus Health. |
| November 6, 2023 | Consensus Health expands its medical group with the addition of five new New Jersey-based physician practices. |
Consensus Health's Current Status
Consensus Health now operates as a leading physician-owned medical group. As of January 2024, it includes over 160 independent primary care providers and specialists across 69 locations in New Jersey, with an Independent Physician Alliance (IPA) encompassing over 600 providers.
Growth and Expansion
Consensus Health has demonstrated significant growth, increasing from 44 to 107 MDs within two years. The company is supported by private equity backing from Ascend Partners and focuses on enhancing operational efficiency and improving patient care through technology.
Future Outlook
The future for Consensus Health involves continued expansion of its network of independent clinicians. It aims to leverage technology for improved patient engagement, streamlined practice workflows, and optimized tools for value-based care, focusing on administrative support and value-based initiatives.
Market Context
The broader healthcare RFID market is projected to reach USD 15.7 billion by 2030, growing at a CAGR of 14.6% from 2024 to 2030. While VeriTeQ Corp. was initially involved in this market, Consensus Health's current focus is on healthcare services and administrative support.
VeriTeQ Corp. Porter's Five Forces Analysis
- Covers All 5 Competitive Forces in Detail
- Structured for Consultants, Students, and Founders
- 100% Editable in Microsoft Word & Excel
- Instant Digital Download – Use Immediately
- Compatible with Mac & PC – Fully Unlocked
Related Blogs
- What is Competitive Landscape of VeriTeQ Corp. Company?
- What is Growth Strategy and Future Prospects of VeriTeQ Corp. Company?
- How Does VeriTeQ Corp. Company Work?
- What is Sales and Marketing Strategy of VeriTeQ Corp. Company?
- What is Brief History of VeriTeQ Corp. Company?
- Who Owns VeriTeQ Corp. Company?
- What is Customer Demographics and Target Market of VeriTeQ Corp. Company?
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.